Cite
HARVARD Citation
Nykiforuk, C. et al. (n.d.). P4‐371: PRECLINICAL DEVELOPMENT OF AN AMYLOID‐B OLIGMER (ABO) SPECIFIC MONOCLONAL ANTIBODY (5E3) FOR POTENTIAL PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S DISEASE. Alzheimer's & dementia. p. P924. [Online].